5 completed, 1 enrolling by invitation, 1 unknown, 1 withdrawn. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 5, Enrolling by invitation 1, Unknown 1, Withdrawn 1 |
Follow Feraheme: new trials by email Literature Review of Feraheme trials Research Report on Feraheme
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nanozymes in Endodontics Nanozyme treatment, Control (Standard treatment) - Apical Periodontitis, Endodontic Disease | Phase 4 | Enrolling by invitation | University of Pennsylvania | 72 | 2026-08-24 | 2026-10-13 |
| Predicting Stroke Risk in ICAD With Novel MRI Feraheme - Intracranial Atherosclerosis | Phase 4 | Withdrawn | Northwestern University | 2020-09-01 | 2026-08-06 | |
| A New Clinical Use of Ferumoxytol Nanoparticles: An Antibiofilm Treatment Iron oxide nanoparticles treatment Ferumoxytol/H2O2, NaOCl, NaCl - Apical Periodontitis, Pulp Disease, Dental | Phase 4 | Completed | University of Pennsylvania | 44 | 2020-07-13 | 2024-08-28 |
| IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding Ferumoxytol, Ferrous Sulfate - Anemia, Iron Deficiency, Heavy Menstrual Bleeding | Phase 4 | Unknown | Thomas Jefferson University | 76 | 2020-02-14 | 2023-11-21 |
| Feraheme As An MRI Contrast Agent For Pediatric Congenital Heart Disease ferumoxytol, gadofosveset - Pediatric Congenital Heart Disease | Phase 4 | Completed | Paul Finn | 17 | 2016-04-01 | 2022-12-28 |
| Ferumoxytol for Iron-Deficiency Anemia in Chronic Kidney Disease and Peritoneal Dialysis Patients Ferumoxytol - Iron-Deficiency Anemia, Inflammation | Phase 4 | Completed | Georges Ouellet | 15 | 2013-09-01 | 2015-04-13 |
| Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis Ferumoxytol, Iron Sucrose - Iron Deficiency Anemia Treatment, Chronic Kidney Disease(CKD) | Phase 4 | Completed | AMAG Pharmaceuticals, Inc. | 296 | 2013-08-01 | 2022-04-21 |
| Iron Indices and Intravenous Ferumoxytol: Time to Steady State ferumoxytol - Iron Deficiency Anemia | Phase 4 | Completed | Dialysis Clinic, Inc. | 15 | 2010-03-01 | 2012-03-30 |
Anemia, Iron-Deficiency (4) · Dental Pulp Diseases (2) · Periapical Periodontitis (2) · Renal Insufficiency, Chronic (2) · Anemia (1) · Constriction, Pathologic (1) · Inflammation (1) · Intracranial Arteriosclerosis (1) · Menorrhagia (1) · Plaque, Amyloid (1) · Stroke (1)
University of Pennsylvania (2) · AMAG Pharmaceuticals, Inc. (1) · Dialysis Clinic, Inc. (1) · Georges Ouellet (1) · Northwestern University (1) · Paul Finn (1) · Thomas Jefferson University (1)
United States (7) · Canada (2) · United Kingdom (1)
Bekir Karabucak, DMD, MS (1) · Georges Ouellet, MD (1) · Sameer A Ansari, MD, PhD (1) · Toros Kapoian, MD (1)